CD8A and cancer: Remarkably, the loss of E-cadherin during epithelial-to-mesenchymal transition corresponds to a mechanism used by cancer stem-cell (CSC)-like cells to evade CD103+CD8+ TRM cell-mediated recognition and destruction (85).